申请人:A. H. Robins Company, Incorporated
公开号:US04045576A1
公开(公告)日:1977-08-30
Novel 2-amino-3-(5- and 6-)benzoylphenylacetic acids, esters and metal salts of the formula: ##STR1## wherein R is hydrogen or lower alkyl, R.sup.1 is hydrogen, lower-alkyl, sodium or potassium, R.sup.2 is hydrogen, halogen or lower alkoxy, X is hydrogen, lower alkyl, halogen, nitro or trifluoromethyl, Y is hydrogen, lower alkyl, halogen, nitro or trifluoromethyl, and Am is primary amino (--NH.sub.2) methylamino or dimethylamino. The compounds are prepared by hydrolysis of 4-(5- and 7-)benzoylindolin-2-ones to give the 2-amino-3-(5- and 6-)benzoylphenylacetic acids wherein amino is primary amino. The free acids are converted to the esters and metal salts. The calcium and magnesium salts are disclosed and are within the scope of the present invention. The compounds have anti-inflammatory activity, are effective in lowering the cholesterol levels in hyperlipemic rats and inhibit blood platelet aggregation.
化合物的式子为:##STR1## 其中R为氢或低烷基,R.sup.1为氢、低烷基、钠或钾,R.sup.2为氢、卤素或低烷氧基,X为氢、低烷基、卤素、硝基或三氟甲基,Y为氢、低烷基、卤素、硝基或三氟甲基,Am为一级氨基(--NH.sub.2)、甲基氨基或二甲基氨基。该化合物通过4-(5-和7-)苯甲酰吲哚-2-酮的水解制备而成,以得到2-氨基-3-(5-和6-)苯甲酰基苯乙酸,其中氨基是一级氨基。游离酸转化为酯和金属盐。本发明公开了钙盐和镁盐。这些化合物具有抗炎活性,在高脂血症大鼠中降低胆固醇水平,并抑制血小板聚集。